| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 10, 2003
From the Department of Pathology (R. A., N. I., M. K., Y. H.), Tokushima University School of Dentistry, and Department of Neurosurgery (K. O., S. N.), University of Tokushima School of Medicine, Tokushima, Japan. * To whom correspondence should be addressed. E-mail: hayashi{at}dent.tokushima-u.ac.jp.
Background and Purpose--Moyamoya disease (MMD) is a rare entity that results in progressive occlusion of the arteries of the circle of Willis, but the pathogenesis of MMD is unknown. Methods--MMD sera (n=32) were tested for anti-endothelial cell antibodies by enzyme-linked immunoassays and flow cytometric analysis. Apoptosis was induced in human umbilical vein endothelial cells by tumor necrosis factor- Results--We found that a high proportion of MMD sera had anti-endothelial cell antibodies with apoptotic stimuli. Prominent reactivities of MMD sera (72%) with recombinant human Conclusions--Our study demonstrates that MMD sera contain a high incidence of anti-
Accepted on July 30, 2003
Anti-
Kouichi Ogawa MD;
-Fodrin Autoantibodies in Moyamoya Disease
.
-fodrin were observed.
-fodrin autoantibodies, providing new insight into the mechanisms of occlusion of MMD arteries.
-fodrin
autoantibodies
moyamoya disease
This article has been cited by other articles:
![]() |
N. Kuroda, T. Mitani, N. Takeda, N. Ishimaru, R. Arakaki, Y. Hayashi, Y. Bando, K. Izumi, T. Takahashi, T. Nomura, et al. Development of Autoimmunity against Transcriptionally Unrepressed Target Antigen in the Thymus of Aire-Deficient Mice J. Immunol., February 15, 2005; 174(4): 1862 - 1870. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |